ROBIN OWENS: Open Payments
NPI 1609352632 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 29 payments from 9 companies in 2025. Trend: 2023 $614 · 2024 $772 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $284 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $190 |
| Kestra Medical Technology Services, Inc. | 3 | $79 |
| Amgen Inc. | 2 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| PFIZER INC. | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: LifeVest, FARXIGA, LOKELMA, Assure WCD, REPATHA, Kerendia, VERQUVO, CAMZYOS.
Industry payments across GA — which companies pay providers there.
